Achieve Life Sciences: Venrock reports 5.2% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah, and Bong Y. Koh reported beneficial ownership of 5,502,064 Achieve Life Sciences, Inc. (ACHV) common shares, or 5.2%, as of September 30, 2026. Shah and Koh are identified as voting members of the management entities.
The shares are held through the three investment vehicles: 3,687,920 by Venrock Healthcare Capital Partners III, L.P.; 368,752 by VHCP Co-Investment Holdings III, LLC; and 1,445,392 by Venrock Healthcare Capital Partners EG, L.P. Each reporting person reported shared voting and dispositive power over 5,502,064 shares and no sole voting or dispositive power. The percentage calculation uses 102,902,490 shares outstanding as of August 11, 2026, plus 2,751,032 shares issued subsequently upon warrant exercises by the reporting persons.
Key Figures
Key Terms
beneficially owned regulatory
Warrants financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How is the reported ACHV stake divided among the investment vehicles?
AI-generated analysis. How Rhea-AI works. Not financial advice.